Related Experiment Videos
Nicked human chorionic gonadotropin in trophoblastic disease
1Yale Trophoblast Center, Department of Obstetrics & Gynecology, Yale University School of Medicine, New Haven, Connecticut, USA.
Summary
The proportion of nicked human chorionic gonadotropin (hCG) increases as trophoblastic disease resolves. Measuring nicked hCG does not offer additional clinical information beyond total hCG measurements for managing patients.
Area of Science:
- Reproductive Endocrinology
- Gynecologic Oncology
- Biochemistry
Background:
- Human chorionic gonadotropin (hCG) is a key biomarker in managing trophoblastic diseases.
- Understanding the different forms of hCG, such as intact and nicked hCG, may offer insights into disease progression and resolution.
- Current management relies on total hCG levels, but the utility of specific hCG forms requires further investigation.
Purpose of the Study:
- To determine if high proportions of nicked hCG indicate trophoblastic malignancy.
- To assess if measuring nicked hCG provides more clinical value than total hCG in managing trophoblastic disease.
Main Methods:
- Serial serum samples from 45 patients with trophoblastic disease were analyzed.
- Measurements included total hCG, intact hCG, and nicked hCG using "tumor marker" assays.
- HCG levels and proportions were tracked during mole evacuation, postmolar surveillance, and chemotherapy.
Main Results:
- At presentation, 83.5% of hCG was intact and 16.5% was nicked.
- These proportions reversed as hCG levels declined post-evacuation or with treatment.
- The proportion of nicked hCG increased as trophoblastic disease resolved.
Conclusions:
- The increase in nicked hCG proportion correlates with trophoblastic disease resolution, not malignancy.
- Measurement of nicked hCG does not provide additional clinically useful information compared to reliable total hCG measurements.